INSPHealthcareSmall-Cap

Inspire Medical Systems, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Inspire Medical Systems, Inc. (INSP), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are INSP insiders buying or selling?

Inspire Medical Systems, Inc. insiders reported 13 open-market buys ($18.5M) and 184 sells ($818.2M) across 197 Form 4 filings — a net selling position of $799.7M.

Source: SEC EDGAR Form 4

Key Statistics (as of May 19, 2026)

Total Form 4 filings
197
SEC EDGAR
Insider filers
19
Insider buys (13)
$18.5M
Insider sells (184)
$818.2M

Insider sentiment

Net selling

Net insider flow of $799.7M in net selling.

Recent INSP insider transactions

DateInsiderRoleTypeSharesPriceValue
May 19, 2026John RondoniTitle: Chief Product and Innovation Officer.Sale2.6K$43.28$114.3K
May 15, 2026John RondoniTitle: Chief Product and Innovation Officer.Sale700$43.01$30.1K
May 11, 2026Shawn MccormickDirectorSale696$45.31$31.5K
Jan 12, 2026John RondoniTitle: Chief Product and Innovation Officer. All sale transactions reported herein were made pursuanSale109$100.00$10.9K
Dec 4, 2025Shawn MccormickDirectorSale1.2K$139.00$166.8K
Dec 1, 2025Shawn MccormickDirectorSale2.0K$127.48$255.0K
Nov 25, 2025Curet MyriamDirectorSale1-$188.07
Sep 3, 2025Richard BuchholzChief Financial OfficerSale11.0K$93.39$1.0M
May 21, 2025John RondoniChief Product and Innovation OfficerSale1.7K$149.38$259.0K
May 5, 2025Shawn MccormickDirectorSale360$160.00$57.6K
Mar 5, 2025Randy BanExecutive Vice President, Patient Access and Therapy Development. All transactions reported herein wSale3.9K$185.84$733.5K
Mar 5, 2025John RondoniChief Technology OfficerSale2.3K$185.60$424.5K
Feb 18, 2025Randy BanExecutive Vice President, Patient Access and Therapy DevelopmentSale25.6K$183.50$4.7M
Feb 14, 2025John RondoniChief Technology OfficerSale583$170.49$99.4K
Jan 10, 2025John RondoniChief Technology OfficerSale58$215.00$12.5K
Nov 5, 2024John RondoniChief Technology OfficerSale8.7K$193.47$1.7M
Sep 11, 2024Shawn MccormickDirectorSale800$220.00$176.0K
Sep 11, 2024John RondoniChief Technology OfficerSale31$215.00$6.7K
Aug 23, 2024John RondoniChief Technology OfficerSale5.0K$189.83$949.1K
Aug 20, 2024Randy BanChief Commercial OfficerSale21.0K$192.05$4.0M
Apr 18, 2024Richard BuchholzChief Financial OfficerSale15.0K$230.03$3.5M
Apr 4, 2024Timothy P. HerbertCEO and PresidentSale40.0K$205.09$8.2M
Apr 3, 2024Jerry C GriffinDirectorSale32$213.99$6.8K
Mar 27, 2024Jerry C GriffinDirectorSale554$197.81$109.6K
Mar 27, 2024John RondoniChief Technology OfficerSale4.4K$194.40$852.8K

Showing the 25 most recent of 197 Form 4 filings for Inspire Medical Systems, Inc..

Most active INSP insiders

  • Timothy P. Herbert29 filings
  • Randy Ban25 filings
  • Jerry C Griffin24 filings
  • Richard Buchholz20 filings
  • John Rondoni15 filings

Ask anything about INSP insider activity

Use Trabud's AI agent to query Inspire Medical Systems, Inc.'s Form 4 history in plain English — "Show me INSP CEO purchases this year" or compare it against any other ticker.

Open the AI agent

INSP insider trading FAQ

Are Inspire Medical Systems, Inc. insiders buying or selling?

Across 197 SEC Form 4 filings, Inspire Medical Systems, Inc. (INSP) insiders reported 13 open-market purchases totaling $18.5M and 184 sales totaling $818.2M. That is a net selling position of $799.7M.

How many insiders trade INSP stock?

19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Inspire Medical Systems, Inc.. The most recent filing was accepted on May 19, 2026.

Where does Trabud get INSP insider trading data?

All INSP insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content